doi:10.19854/j.cnki.1008-2425.2025.05.0010

Abstract

摘要： 帕金森病(PD)除典型运动症状外,常伴有抑郁、焦虑等情感障碍,严重影响患者生活质量、治疗依从性及神经外科干预效果。临床识别面临困境:情感症状非典型、与运动症状交织,现有评估手段敏感性与特异性不足。其病理机制涉及情绪调控环路的结构与功能异常。近年来,多模态生物标志物为客观识别提供新途径:EEG可捕捉毫秒级情绪动态,fMRI揭示网络连接异常,眼动指标提供无创行为学补充。基于机器学习的多模态融合策略整合电生理、影像及行为数据,提升识别准确性与泛化能力,未来嵌入闭环神经调控系统,有望实现情绪状态驱动的个体化干预。本文综述PD情感障碍的识别困境与机制,探讨多模态方法在精准调控中的转化前景。

关键词: 帕金森病, 抑郁症, 焦虑症, 多模态生物标志物, 闭环脑深部电刺激

CLC Number:

742.5

张雨杨, 张宇清. 帕金森病情感障碍的多模态识别研究进展与闭环调控展望[J]. 立体定向和功能性神经外科杂志, 2025, 38(5): 315-320.

References

[1] Xu TL,Dong WL,Liu JL,et al.Disease burden of parkinson's disease in China and its provinces from 1990 to 2021:findings from the global burden of disease study 2021[J].Lancet Reg Health.West Pac,2024,46:101078.
[2] Xia DH,Xiong M,Yang YX,et al.Chronic stress induces depression-like behaviors and Parkinsonism via upregulating α-synuclein[J].NPJ Parkinson's Dis,2025,11(1):139.
[3] Reijnders JS AM,Ehrt U,Weber WEJ,et al.A systematic review of prevalence studies of depression in parkinson's disease[J].Mov Disord,2008,23(2):183~189.
[4] Cong SR,Xiang CC,Zhang S,et al.Prevalence and clinical aspects of depression in Parkinson's disease:A systematic review and meta-analysis of 129 studies[J].Neurosci Biobehav Rev,2022,141:104749.
[5] Cui SS,Du JJ,Fu R,et al.Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease[J].BMC Geriatr,2017,17(1):270.
[6] Lutz SG,Holmes JD,Ready EA,et al.Clinical presentation of anxiety in Parkinson's disease:a scoping review[J].OTJR:Occup,Ther J Res,2016,36(3):134~147.
[7] Shanechi M M.Brain-machine interfaces from motor to mood[J].Nat Neurosci,2019,22(10):1554~1564.
[8] Kirkby LA,Luongo FJ,Lee MB,et al.An amygdala-hippocampus subnetwork that encodes variation in human mood[J].Cell,2018,175(6):1688~1700.
[9] Ding XE,Yue XX,Zheng R,et al.Classifying major depression patients and healthy controls using EEG,eye tracking and galvanic skin response data[J].J Affect Disord,2019,251:156~161.
[10] Li QH,Wang KL,Li JP,et al.Adaptive vs conventional deep brain stimulation of the subthalamic nucleus for treatment of Parkinson's disease:a multicenter retrospective study[J].Neuromodulation:Technol Neural Interface,,2025:S1094~S7159.
[11] Shulman LM,Taback RL,Rabinstein A A,et al.Non-recognition of depression and other non-motor symptoms in parkinson's disease[J].Park Relat Disord,2002,8(3):193~197.
[12] Timmer MHM,van Beek MHC T,Bloem B R,et al.What a neurologist should know about depression in parkinson's disease[J].Pract Neurol,2017,17(5):359~368.
[13] Leentjens AFG,Dujardin K,Pontone GM,et al.The parkinson anxiety scale (PAS):Development and validation of a new anxiety scale[J].Mov Disord,2014,29(8):1035~1043.
[14] Rodriguez-Blazquez C,Frades-Payo B,Forjaz M J,et al.Psychometric attributes of the hospital anxiety and depression scale in parkinson's disease[J].Mov Disord,2009,24(4):519~525.
[15] Schrag A,Barone P,Brown RG,et al.Depression rating scales in parkinson's disease:Critique and recommendations[J].Mov Disord,2007,22(8):1077~1092.
[16] Zimmerman M,Posternak MA,Chelminski I.Is it time to replace the hamilton depression rating scale as the primary outcome measure in treatment studies of depression[J].J Clin Psychopharmacol,2005,25(2):105~110.
[17] Leentjens AFG,Dujardin K,Marsh L,et al.Anxiety rating scales in parkinson's disease:Critique and recommendations[J].Mov Disord,2008,23(14):2015~2025.
[18] Leentjens AFG,Dujardin K,Marsh L,et al.Anxiety rating scales in parkinson's disease:A validation study of the hamilton anxiety rating scale,the beck anxiety inventory,and the hospital anxiety and depression scale[J].Mov Disord,2011,26(3):407~415.
[19] Mayberg H S,Solomon D H.Depression in parkinson's disease:A biochemical and organic viewpoint[J].Advances in Neurology,1995,65:49~60.
[20] Mayberg HS,Starkstein SE,Sadzot B,et al.Selective hypometabolism in the inferior frontal lobe in depressed patients with parkinson's disease[J].Ann Neurol,1990,28(1):57~64.
[21] Kostiĉ VS,Agosta F,Petroviĉ I,et al.Regional patterns of brain tissue loss associated with depression in parkinson disease[J].Neurology,2010,75(10):857~863.
[22] Torack RM,Morris JC.The association of ventral tegmental area histopathology with adult dementia[J].Arch Neurol,1988,45(5):497~501.
[23] Blomstedt P,Hariz M I,Lees A,et al.Acute severe depression induced by intraoperative stimulation of the substantia nigra:A case report[J].Park Relat Disord,2008,14(3):253~256.
[24] Remy P,Doder M,Lees A,et al.Depression in parkinson's disease:loss of dopamine and noradrenaline innervation in the limbic system[J].Brain,2005,128(6):1314~1322.
[25] Zhao J,Jia H,Ma P,et al.Multidimensional mechanisms of anxiety and depression in Parkinson's disease:Integrating neuroimaging,neurocircuits,and molecular pathways[J].Pharmacol Res,2025,215:107717.
[26] Armstrong MJ,Okun MS.Diagnosis and treatment of parkinson disease:a review[J].JAMA,2020,323(6):548~560.
[27] Allen JJB,Keune PM,Schönenberg M,et al.Frontal EEG alpha asymmetry and emotion:From neural underpinnings and methodological considerations to psychopathology and social cognition[J].Psychophysiology,2018,55(1):e13028.
[28] Shen AR,Sun JN,Chen XG,et al.A data-centric and interpretable EEG framework for depression severity grading using SHAP-based insights[J].J NeuroEngineering Rehabil,2025,22(1):116.
[29] Kan DPX,Lee PF.Decrease alpha waves in depression:An electroencephalogram(EEG) study[C]//2015 International Conference on BioSignal Analysis,Processing and Systems (ICBAPS)[J]Kuala Lumpur,Malaysia:IEEE,2015:156~161.
[30] Zhou P,Wu Q,Zhan L,et al.Alpha peak activity in resting-state EEG is associated with depressive score[J].Front Neurosci,2023,17:1057908.
[31] Strik WK,Dierks T,Becker T,et al.Larger topographical variance and decreased duration of brain electric microstates in depression[J].J Neural Transm.Gen Sect JNT,1995,99(1-3):213~222.
[32] Ostlund BD,Alperin BR,Drew T,et al.Behavioral and cognitive correlates of the aperiodic (1/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD[J].Dev Cogn Neurosci,2021,48:100931.
[33] Yassine S,Almarouk S,Gschwandtner U,et al.Electrophysiological signatures of anxiety in parkinson's disease[J].Transl Psychiatry,2024,14(1):66.
[34] Luo C,Chen Q,Song W,et al.Resting-state fMRI study on drug-naive patients with parkinson's disease and with depression[J].J Neurol Neurosurg Psychiatry,2014,85(6):675~683.
[35] Tang YY,Tang ZY,Zhou Y,et al.A systematic review of resting-state functional-MRI studies in the diagnosis,comorbidity and treatment of postpartum depression[J].J Affect Disord,2025,383:153~166.
[36] Zugman A,Jett L,Antonacci C,et al.A systematic review and meta-analysis of resting-state fMRI in anxiety disorders:Need for data sharing to move the field forward[J].J Anxiety Disord,2023,99:102773.
[37] Yuan C,Zhu H,Ren Z,et al.Precuneus-related regional and network functional deficits in social anxiety disorder:A resting-state functional MRI study[J].Compr Psychiatry,2018,82:22~29.
[38] ErgülC,Ulaşoĝlu Yildiz Ç,Kurt E,et al.Evaluation of resting-state functional magnetic resonance imaging findings of patients with social anxiety disorder[J].Turk J Psychiatry,2022,33(2):73~81.
[39] Meng LL,Zhang YD,Lin H,et al.Abnormal hubs in global network as potential neuroimaging marker in generalized anxiety disorder at rest[J].Front Psychol,2022,13:1075636.
[40] Suslow T,Hußlack A,Kersting A,et al.Attentional biases to emotional information in clinical depression:A systematic and meta-analytic review of eye tracking findings[J].J Affect Disord,2020,274:632~642.
[41] Günther V,Kropidlowski A,Schmidt FM,et al.Attentional processes during emotional face perception in social anxiety disorder:A systematic review and meta-analysis of eye-tracking findings[J].Prog Neuro-Psychopharmacology Biol Psychiatry,2021,111:110353.
[42] Stevens S,Rist F,Gerlach AL.Eye movement assessment in individuals with social phobia:Differential usefulness for varying presentation times[J].J Behav Ther Exp Psychiatry,2011,42(2):219~224.
[43] Horley K,Williams L M,Gonsalvez C,et al.Face to face:Visual scanpath evidence for abnormal processing of facial expressions in social phobia[J].Psychiatry Res,2004,127(1-2):43~53.
[44] Boll S,Bartholomaeus M,Peter U,et al.Attentional mechanisms of social perception are biased in social phobia[J].J Anxiety Disord,2016,40:83~93.
[45] Wu W,Zhang C,Woodland PC.Self-supervised representations in speech-based depression detection[C]//ICASSP 2023 - 2023 IEEE International Conference on Acoustics,Speech and Signal Processing (ICASSP),2023:1~5.
[46] Lam G,Huang DY,Lin WS.Context-aware deep learning for multi modal depression detection[C]//ICASSP 2019 - 2019 IEEE International Conference on Acoustics,Speech and Signal Processing (ICASSP).2019:3946~3950.
[47] Niu MY,Tao JH,Liu B,et al.Multimodal spatiotemporal representation for automatic depression level detection[J].IEEE Transactions on Affective Computing,2023,14(1):294~307.
[48] He L,Chan JC,Wang ZM.Automatic depression recognition using CNN with attention mechanism from videos[J].Neurocomputing,2021,422:165~175.
[49] Zhao ZP,Bao ZT,Zhang ZX,et al.Automatic assessment of depression from speech via a hierarchical attention transfer network and attention autoencoders[J].IEEE J Sel Top Signal Process,2020,14(2):423~434.
[50] Baevski A,Zhou H,Mohamed A,et al.wav2vec 2.0:A framework for self-supervised learning of speech representations[A].arXiv,2020.

帕金森病情感障碍的多模态识别研究进展与闭环调控展望

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Xiaochen, Zhu Shanshan, Zhang Jing, Zhang Jianbin, Zhao Siren, Tian Yanyan, Liang Sisi. Analysis of the Impact of Deep Brain Stimulation on Non-motor Symptoms and Quality of Life in Patients with Parkinson's Disease Based on a Retrospective Cohort Study [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(3): 129-134.
[2]	Zhen Sumeng, Hu Fangting, Wang Jing. A longitudinal study of disease influencing factors for fear of disease progression in first diagnosis Parkinson's patients [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(2): 71-76.
[3]	Liao Sha, Wang Zhongming, Li Yong. Clinical application of accelerated rehabilitation surgery for early postoperative cognitive function protection in patients with refractory epilepsy [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(2): 84-90.
[4]	. [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(2): 119-124.
[5]	. [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(1): 52-55.
[6]	Haihua Zhao, Cai Ming. Clinical study of serum vitamin D level and sympathetic skin response in patients with Parkinson's disease [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(3): 134-140.
[7]	Lu Xia, Zhang Dan, Jiang ZhaoXing, Li Peihan, Wang Hui. Correlation between autonomic nervous dysfunction and cerebral blood flow change in decubitus position in Parkinson's disease [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(1): 1-5.
[8]	. [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(1): 54-62.
[9]	Niu Chaoshi, Chen peng, Xiong Chi. Rechargeable and remote programmable 3.0T magnetic resonance compatible deep brain stimulation system for the treatment of Parkinson's disease:a one-year follow-up clinical effect and imaging analysis [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(6): 321-326.
[10]	Wang Jue, Qiu Xian, Gao Ying, et al. A two-year survey on non-motor symptoms after bilateral subthalamic nucleus deep brain stimulation in patients with Parkinson's disease [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(4): 193-199.
[11]	Hannipa ·Tolegen, Zhang La. Clinical significance of anal sphincter electromyography in patients with Parkinson's disease associated with autonomic dysfunction [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(4): 200-204.
[12]	. Significance of miR-146a expression in Parkinson's patients and analysis of its correlation with inflammatory factors [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(2): 65-70.
[13]	. Clinical application of transcranial substantia nigra ultrasound in patients with Parkinson's disease accompanied by hypoceruloplasminemia [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(2): 71-75.
[14]	. Analysis of the relationships between changes in polysomnographic EEG map features and cognitive dysfunction in patients with Parkinson's disease [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(2): 76-81.
[15]	. [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(2): 122-128.